HomeCompareRPHCF vs DIVO

RPHCF vs DIVO: Dividend Comparison 2026

RPHCF yields 1.82% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHCF wins by $43.20M in total portfolio value· pulled ahead in Year 3
10 years
RPHCF
RPHCF
● Live price
1.82%
Share price
$15.20
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.23M
Annual income
$39,107,153.37
Full RPHCF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — RPHCF vs DIVO

📍 RPHCF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHCFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHCF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHCF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHCF
Annual income on $10K today (after 15% tax)
$154.90/yr
After 10yr DRIP, annual income (after tax)
$33,241,080.36/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, RPHCF beats the other by $33,240,245.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHCF + DIVO for your $10,000?

RPHCF: 50%DIVO: 50%
100% DIVO50/50100% RPHCF
Portfolio after 10yr
$21.63M
Annual income
$19,554,067.53/yr
Blended yield
90.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHCF right now

RPHCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
5/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHCF buys
0
DIVO buys
0
No recent congressional trades found for RPHCF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHCFDIVO
Forward yield1.82%6.49%
Annual dividend / share$0.28$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$43.23M$30.7K
Annual income after 10y$39,107,153.37$981.68
Total dividends collected$42.89M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RPHCF vs DIVO ($10,000, DRIP)

YearRPHCF PortfolioRPHCF Income/yrDIVO PortfolioDIVO Income/yrGap
1$11,064$364.47$11,349$649.42$285.00DIVO
2$12,593$753.78$12,833$688.83$240.00DIVO
3← crossover$15,078$1,603.54$14,459$727.90+$619.00RPHCF
4$19,722$3,588.75$16,238$766.49+$3.5KRPHCF
5$29,877$8,774.08$18,179$804.47+$11.7KRPHCF
6$56,812$24,844.41$20,293$841.71+$36.5KRPHCF
7$149,094$88,305.24$22,591$878.14+$126.5KRPHCF
8$592,694$433,162.94$25,087$913.65+$567.6KRPHCF
9$3,852,779$3,218,596.09$27,791$948.18+$3.82MRPHCF
10$43,229,627$39,107,153.37$30,718$981.68+$43.20MRPHCF

RPHCF vs DIVO: Complete Analysis 2026

RPHCFStock

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Full RPHCF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this RPHCF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHCF vs SCHDRPHCF vs JEPIRPHCF vs ORPHCF vs KORPHCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.